Le Lézard
Classified in: Health
Subjects: MAV, CCA

WELL Health to Host Second Quarter 2019 Investor Conference Call

VANCOUVER, Aug. 19, 2019 /CNW/ - WELL Health Technologies Corp. ("WELL") (TSX.V: WELL), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, will hold a call to discuss its 2019 second quarter financial results on Thursday August 22, 2019 at 1:00 pm ET (10:00 am PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer; Eva Fong, Chief Financial Officer and Pardeep S. Sangha Vice President Corporate Strategy and Investor Relations.

Conference Call Details:
Date:  Thursday August 22, 2019
Time:  1:00 pm Eastern Time (10:00 am Pacific Time)
Dial-in:  1-416-764-8609 (Toronto local) or 1-888-390-0605 (Toll-Free)
Conference ID:  54030543

Replay accessible for 7 days:
Replay dial-in: 1-416-764-8677 or 1-888-390-0541
Playback passcode:  030543#

About WELL

WELL is a unique company that operates Primary Healthcare Facilities as well as a significant EMR or Electronic Medical Records business that supports the digitization of such clinics.  WELL's overarching objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.  In the last 12 months, WELL physicians served approximately 600,000 patient visits through its network of 19 medical clinics.  WELL is publicly traded on the TSX Venture Exchange under the symbol WELL.V.  WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE WELL Health Technologies Corp.

These press releases may also interest you

at 17:05
California Life Sciences Association (CLSA), the trade association representing California's life sciences sector, issued the following statement in response to House Speaker Nancy Pelosi's drug pricing proposal unveiled today. This statement can be...

at 17:00
Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, will present new data from a Phase 2 clinical trial evaluating tavapadon (formerly PF-06649751) in patients with early-stage...

at 17:00
The "Effective Training Skills and Processes in the Pharma Industry" conference has been added to ResearchAndMarkets.com's offering. Interactive course ideal for anyone with responsibility for planning or delivering training in the Pharma, Device or...

at 17:00
Vireo Health International, Inc. ("Vireo" or the "Company") , a leading science-focused, multi-state cannabis company, today announced that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States....

at 16:45
The "EU Pharmaceutical Regulations & Strategy" conference has been added to ResearchAndMarkets.com's offering This course will provide an up-to-date overview of the European pharmaceutical regulatory environment, procedures, and obligations. You...

at 16:43
Dallas-based MedCore Partners recently added two members to its Senior Living team amidst the continued growth of its seniors housing platform. Anthony Fulco joined MedCore in August as the Seniors Housing Director of Acquisitions. Mr. Fulco brings...

News published on 19 august 2019 at 18:56 and distributed by: